X T L Biopharmaceuticals Ltd ADR (XTLB)

Currency in USD
2.160
+0.030(+1.41%)
Closed·
2.1500.000(0.00%)
·
XTLB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.1602.213
52 wk Range
0.78410.280
Key Statistics
Prev. Close
2.16
Open
2.17
Day's Range
2.16-2.213
52 wk Range
0.784-10.28
Volume
6.74K
Average Volume (3m)
10.46K
1-Year Change
-54.0426%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
XTLB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Short term obligations exceed liquid assets
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Earnings

Latest Release
30/12/2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
517K / --
EPS Revisions
Last 90 days

XTLB Income Statement

Compare XTLB to Peers and Sector

Metrics to compare
XTLB
Peers
Sector
Relationship
P/E Ratio
−10.8x−0.4x−0.3x
PEG Ratio
0.030.000.00
Price/Book
−32.2x0.9x2.6x
Price / LTM Sales
-1.9x3.0x
Upside (Analyst Target)
-41.9%58.6%
Fair Value Upside
Unlock8.2%8.4%Unlock

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel. The company’s lead drug candidate is hCDR1, which is a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren’s syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Herzliya, Israel.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.04M0.08%2.38M
Other Institutional Investors
3.03M0.23%6.96M
Public Companies & Retail Investors
1.32B99.69%3.04B
Total
1.32B100.00%3.05B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Rhumbline Advisers Ltd Partnership0.19%2,491,2005,730
FMR LLC0.04%546,8001,258

People Also Watch

0.235
VNRX
0.00%
3.22
APUS
-21.46%
1.130
ADCT
+4.63%
18.610
OMER
+0.76%
2.6400
MTNB
+9.09%

FAQ

What Is the X T L Bio ADR (XTLB) Stock Price Today?

The X T L Bio ADR stock price today is 2.160 USD.

What Stock Exchange Does X T L Bio ADR Trade On?

X T L Bio ADR is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for X T L Bio ADR?

The stock symbol for X T L Bio ADR is "XTLB."

What Is the X T L Bio ADR Market Cap?

As of today, X T L Bio ADR market cap is 8.240M USD.

What Is X T L Bio ADR's Earnings Per Share (TTM)?

The X T L Bio ADR EPS (TTM) is -0.001.

From a Technical Analysis Perspective, Is XTLB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has X T L Bio ADR Stock Split?

X T L Bio ADR has split 3 times.

How Many Employees Does X T L Bio ADR Have?

X T L Bio ADR has 5 employees.

What is the current trading status of X T L Bio ADR (XTLB)?

As of 03/10/2026, X T L Bio ADR (XTLB) is trading at a price of 2.160 USD, with a previous close of 2.160 USD. The stock has fluctuated within a day range of 2.160 USD to 2.213 USD, while its 52-week range spans from 0.784 USD to 10.280 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.